Iron Overload - 26 Studies Found
Completed |
: Changes in Pituitary Iron and Volume With Deferasirox : Iron Overload : 2011-06-17 |
Completed |
: Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis :
: 2006-11-01 : Drug: Deferasirox (ICL670) |
Completed |
: Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload :
: 2008-01-14 : |
Completed |
: Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload :
: 2009-12-23 : Drug: FBS0701 Oral FBS0701 for 7 days at one of the following doses: 3 mg/kg/day or 8 mg/kg/day or 16 mg |
Completed |
: Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload :
: 2010-08-19 : Drug: SPD602 (FBS0701, SSP-004184) Oral FBS0701 taken one time daily for up to 96 weeks. |